Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Vile

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Human Gene Therapy|July 8, 1999
Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectorsA Melcher, S Murphy, R Vile
Critical Reviews in Oncology/Hematology|May 23, 2001
Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectorsE Galanis, R Vile, S J Russell
Gene Therapy|September 1, 1994
A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genesR Vile, N Miller, Y Chernajovsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2000
Apoptosis or necrosis for tumor immunotherapy: what's in a name?A Melcher, M Gough, S Todryk, et al.
Gene Therapy|September 22, 1999
Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectorsK W Peng, R Vile, F L Cosset, et al.
Cancer Letters|October 25, 2001
Cell death associated with genetic prodrug activation therapy of colorectal cancerS Todryk, A Melcher, G Bottley, et al.
World Neurosurgery|March 15, 2022
Posttraumatic Amnesia: A Systematic Review and Meta-Analysis. Proposal for a New Severity ClassificationAlexander R Vile, Kevin Jang, Dugald Gourlay, et al.
Gene Therapy|May 30, 2008
Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replicationS Guedan, A Gros, M Cascallo, et al.
Lancet (London, England)|January 15, 1998
Genetic prodrug activation therapyL A Martin, R Vile, N R Lemoine, et al.
Eye (London, England)|March 10, 2012
Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanomaJ S Pulido, I Canal, D Salomão, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Human Gene Therapy|July 8, 1999
Heat shock protein expression in target cells infected with low levels of replication-competent virus contributes to the immunogenicity of adenoviral vectorsA Melcher, S Murphy, R Vile
Critical Reviews in Oncology/Hematology|May 23, 2001
Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectorsE Galanis, R Vile, S J Russell
Gene Therapy|September 1, 1994
A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL-2 genesR Vile, N Miller, Y Chernajovsky, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 22, 2000
Apoptosis or necrosis for tumor immunotherapy: what's in a name?A Melcher, M Gough, S Todryk, et al.
Gene Therapy|September 22, 1999
Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectorsK W Peng, R Vile, F L Cosset, et al.
Cancer Letters|October 25, 2001
Cell death associated with genetic prodrug activation therapy of colorectal cancerS Todryk, A Melcher, G Bottley, et al.
World Neurosurgery|March 15, 2022
Posttraumatic Amnesia: A Systematic Review and Meta-Analysis. Proposal for a New Severity ClassificationAlexander R Vile, Kevin Jang, Dugald Gourlay, et al.
Gene Therapy|May 30, 2008
Syncytia formation affects the yield and cytotoxicity of an adenovirus expressing a fusogenic glycoprotein at a late stage of replicationS Guedan, A Gros, M Cascallo, et al.
Lancet (London, England)|January 15, 1998
Genetic prodrug activation therapyL A Martin, R Vile, N R Lemoine, et al.
Eye (London, England)|March 10, 2012
Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanomaJ S Pulido, I Canal, D Salomão, et al.
Pageof 5